Skip to main content

What the FDA labels say about taking them together

Glyburide and probenecid

Glyburide's FDA label of July 1, 2021 names probenecid in its drug interactions section; probenecid's label does not name glyburide itself but warns about its class (Sulfonylureas).

Check it at the source: the glyburide FDA label on DailyMed (effective July 1, 2021, TEVA Pharmaceuticals USA Inc); the probenecid FDA label on DailyMed (effective January 5, 2021, Lannett Company, Inc.).

What does the glyburide label say about probenecid?

Glyburide label, drug interactions

Drug Interactions The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, ACE inhibitors, disopyramide, fluoxetine, clarithromycin, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, monoamine oxidase inhibitors, and beta adrenergic blocking agents.

Source: FDA drug label (Glyburide), NDA017532 (Sanofi Aventis Us), as published by TEVA Pharmaceuticals USA Inc, effective July 1, 2021 (SPL set 50d16f1d-c814-4411-8749-62561321ecce), via openFDA; the full label on DailyMed

What does the probenecid label say about glyburide?

Probenecid's label does not name glyburide itself; it warns about its class (Sulfonylureas):

Probenecid label, drug interactions

Probenecid may prolong or enhance the action of oral sulfonylureas and thereby increase the risk of hypoglycemia.

Source: FDA drug label (Probenecid), Lannett Company, Inc., effective January 5, 2021 (SPL set ab497fd8-00c3-4364-b003-b39d21fbdf38), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Glyburide generic labelers
6Probenecid generic labelers
GlyburideProbenecid
Labeled forType 2 diabetesGout
Boxed warningNoNo
Pharmacy cost (NADAC)$0.0643 per tablet 5 mg tablet$0.636 per tablet 500 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?